These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30106970)

  • 1. Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
    Barbolosi D; Crona J; Serre R; Pacak K; Taieb D
    PLoS One; 2018; 13(8):e0201303. PubMed ID: 30106970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of metastatic pheochromocytoma and paraganglioma in
    Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
    J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
    Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
    Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
    Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
    JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report.
    Chen H; Yao W; He Q; Yu X; Bian B
    BMC Med Genet; 2020 May; 21(1):116. PubMed ID: 32460727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck.
    Ding Y; Feng Y; Wells M; Huang Z; Chen X
    Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the SDHB and SDHD genes.
    Pawlu C; Bausch B; Neumann HP
    Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
    Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
    Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis.
    van Hulsteijn LT; Dekkers OM; Hes FJ; Smit JW; Corssmit EP
    J Med Genet; 2012 Dec; 49(12):768-76. PubMed ID: 23099648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.
    Timmers HJ; Pacak K; Bertherat J; Lenders JW; Duet M; Eisenhofer G; Stratakis CA; Niccoli-Sire P; Tran BH; Burnichon N; Gimenez-Roqueplo AP
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):561-6. PubMed ID: 17973943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma.
    Thompson MJ; Parameswaran V; Burgess JR
    Ann Clin Biochem; 2019 Jan; 56(1):163-169. PubMed ID: 30373390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
    Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K
    BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.